Sartorius to acquire select Danaher Life Science platform biz

Sartorius Stedim Biotech (SSB) has agreed to acquire parts of Danaher’s Life Science portfolio as part of a broade...

October 21, 2019 | Monday | News
Shimmer’s Verisense Continuous Monitoring Platform to Study Breast Cancer-related Fatigue

Shimmer Research, a global leader in wearable technology for research applications, on 10 Oct 2019, announced that a tea...

October 10, 2019 | Thursday | News
Roche reports strong sales growth in 2019

Commenting on the Group’s results, Roche CEO Severin Schwan said: “The uptake of our newly introduced medici...

October 17, 2019 | Thursday | News
BioIVT Acquires PPA Research Group enhancing its R&D capabilities

BioIVT, a leading provider of research models and services for drug and diagnostic development, on 16 Oct 2019, announce...

October 17, 2019 | Thursday | News
Certara Celebrates 20th Anniversary of the Simcyp Simulator Consortium

Certara®, the global model-informed drug development and decision support leader, today announced that it is celebra...

October 17, 2019 | Thursday | News
ImaginAb inks pact with three global pharma companies

ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company has announced the signing of a multi-party coll...

October 15, 2019 | Tuesday | News
PerkinElmer unveils innovative genetic testing kit

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has introduced its PG-Seq™ Rapid...

October 16, 2019 | Wednesday | News
Abbott, Omada Health offer integrated solution for diabetes treatment

Abbott and Omada Health have announced that they are partnering to integrate Abbott's revolutionary FreeStyle Libre syst...

October 15, 2019 | Tuesday | News
Lilly's Migraine drug receives FDA approval

Eli Lilly and Company  has announced that the U.S. Food and Drug Administration (FDA) has approved REYVOW...

October 14, 2019 | Monday | News
NIH strategic research plan addresses tickborne diseases threat

The incidence of reported cases of tickborne diseases in the United States has significantly increased in recent years. ...

October 14, 2019 | Monday | News
Merck acquires FloDesign Sonics

Merck, a leading science and technology company, has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, d...

October 11, 2019 | Friday | News
Bayer launches LifeHub UK focused on AI for drug discovery

Bayer has launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing ...

October 11, 2019 | Friday | News
Novo Nordisk, bluebird bio plan next-gen in vivo genome editing

US headquartered bluebird bio, Inc. and Denmark based Novo Nordisk have announced that they have entered into a three-ye...

October 11, 2019 | Friday | News
Noble Prize in Medicine 2019 for US, UK scientists

The Nobel Prize in Physiology or Medicine for 2019 has been jointly awarded to three winners, William G. Kaelin Jr., Pet...

October 7, 2019 | Monday | News
Study: High lead levels during pregnancy linked to child obesity

Children born to women who have high blood levels of lead are more likely be overweight or obese, compared to those whos...

October 4, 2019 | Friday | Analysis
Scientists in UK identify cause of antibiotic resistance

Scientists have confirmed for the first time that bacteria can change form to avoid being detected by antibiotics in the...

October 4, 2019 | Friday | News
Novartis and Microsoft to transform medicine with AI

Novartis has announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selec...

October 3, 2019 | Thursday | News
AstraZeneca divests rights for Losec to Cheplapharm

AstraZeneca, a global, science-led biopharmaceutical company has agreed to sell the global commercial rights, excluding ...

October 3, 2019 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls